We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App





Sekisui Diagnostics Showcases Clinical Chemistry and Immunoassay Analyzers

By LabMedica International staff writers
Posted on 31 Jul 2018
Sekisui Diagnostics (Lexington, MA, USA) showcased its clinical chemistry and immunoassay analyzers, including the SK500 clinical chemistry system and FastPack IP System, at the 70th Annual Scientific Meeting & Clinical Lab Expo held by the American Association for Clinical Chemistry (AACC) on July 29 – August 2, 2018 in Chicago, USA. More...
AACC is the largest global scientific conference and tradeshow in laboratory medicine, with ~20,000 attendees and 750 exhibitors from around the world. AACC 2018 also provided Plenary Sessions featuring world-renowned scientists and scientific sessions covering a broad range of subjects at various experience levels, and focused “Brown Bag” sessions that gave attendees the opportunity to pose questions in small groups.

Sekisui Diagnostics provides diagnostic products in the areas of diabetes, infectious disease, coagulation, diagnostic enzymes and automated systems. The company’s product lines include clinical chemistry systems and reagents, coagulation systems and reagents, point of care rapid tests and immunoassay system, enzymes and specialty biochemical.

The SK500 Clinical Chemistry System showcased by Sekisui Diagnostics at AACC 2018 is a compact and efficient instrument with a full menu of high quality reagents specifically designed and packaged for the system, including the addition of a drugs of abuse testing menu. Sekisui Diagnostics also showcased the FastPack IP System, a fully automated quantitative immunoassay analyzer which uses sophisticated chemiluminescence technology to deliver accurate test results for commonly ordered tests in 12 minutes or less with a push of a button.

Also featured at the event was the company’s recently launched Silaris Influenza A&B Test which utilizes an affordable, polymerase chain reaction (PCR) testing platform specifically for point of care infectious disease diagnosis. It offers the simplicity, convenience and procedural familiarity of traditional visual read rapid tests, while providing the superior sensitivity and specificity of laboratory-based PCR testing.


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Serological Pipet Controller
PIPETBOY GENIUS
New
Hemoglobin Stool Test
CerTest FOB 50 + 200 One Step Combo Card Test
New
PBC Assay
Primary Biliary Cholangitis Assays
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Non-coding RNAs CBR3-AS1 and PCA3 can be utilized as therapeutic targets and prognostic biomarkers in gastric cancer (Photo courtesy of Adobe Stock)

Promising Molecular Markers Support Earlier Diagnosis of Gastric Cancer

Late detection continues to make gastric cancer one of the leading causes of cancer-related deaths globally. With improved early detection tools urgently needed, researchers have now identified two long... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: The new technology combines a rapid hemoglobin test with a smartphone app (Photo courtesy of 123RF)

Smartphone-Based Rapid Hemoglobin Test Accurately Detects Colorectal Cancer

Despite the availability of colorectal cancer screening programs, participation remains low, especially for fecal immunochemical tests (FIT), a non-invasive method to detect hidden blood in the stool.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.